GU Cancers 2024 | Salvage radiotherapy in biochemically recurrent prostate cancer

Alan Dal Pra, MD, University of Miami, Miami, FL, discusses the role of salvage radiotherapy for local recurrence after radiotherapy. Whilst PSMA PET and biopsies are important in terms of treatment management, there is no standard of care management strategy. Multiple studies have suggested salvage brachytherapy and stereotactic body radiotherapy (SBRT) to be efficacious in certain groups of patients. Patients with negative PSMA PET scores additionally have better clinical outcomes when receiving salvage radiotherapy. This interview took place at the ASCO GU Cancers Symposium 2024 in San Francisco, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.